FCFarah Chohan

Farah Chohan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Farah Chohan has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical Insights into Idiopathic Stroke in Young Adults: A Multi-Case Review

    by Mark Dickinson, Farah Chohan, Jose Ortega-Tola, Ayesha Shahab, Lester Jan Olimba, Parth Vikram Singh, Sahithya Ekasi, Ahad Waraich, Mohan Deochand, George Michel

    Incidence of stroke has risen in young adults under 45 years of age globally. In this case series, we present three cases of stroke in young adults without pre-existing medical conditions. Our first case is a 43-year-old female cruise line employee from Thailand who experienced dizziness and loss of consciousness following a fall 8 days prior, revealing an acute left cerebellar stroke on CT scan. The second case involves a 42-year-old male from the Philippines, with no significant medical history, transferred from Bermuda after being found unresponsive on a cruise ship, with CT brain imaging showing right basal ganglia intracerebral hemorrhage. The third case is a 22-year-old male from Pakistan presenting with a two-day history of severe occipital headache, vomiting, and confusion, revealing intracerebral hemorrhage in the right occipital lobe on CT scan. Discussion focuses on the rising incidence of strokes in young adults, regional disparities, risk factors, and the need for tailored interventions. This review emphasizes the importance of ongoing research and increased awareness and high index of suspicion to improve outcomes in this vulnerable population, particularly among Asians, aiming to mitigate the devastating impact of strokes in this age group.

  • Open Access

    A Rare Case of Myxedema Coma Precipitated by a Single Dose of Haloperidol in a Patient With Paranoid Schizophrenia

    by Manuel Menendez, Temimilola Majekodunmi, Farah Chohan, Aaron Perez-Castaneda, Hiram Maldonado Rivera, Eugenio Angueira-Serrano, George Michel

    Myxedema coma is a rare and potentially life-threatening condition that occurs when severe hypothyroidism is untreated or inadequately managed. It is characterized by a rapid drop in mental status, hypothermia, respiratory failure, hypotension, and other symptoms of severe metabolic dysfunction. The condition primarily affects older women with a history of thyroid dysfunction but can occur in any age or gender group. A common trigger for this condition is seen with a drop in atmospheric temperatures or during the cold winter months. However, a rare, poorly documented trigger is recent antipsychotic use in severe hypothyroid states. The diagnosis of myxedema coma requires prompt recognition and treatment, as delays can result in significant morbidity and mortality which is the objective of this case report.


  • Open Access

    Clinical Presentation of a Patient With Tuberculous Myocarditis: Case Report and Review of Literature

    by Vamsidhar Vennamaneni, Farah Chohan, Pedram Rad, James Rodriguez, Ravi Gupta, George Michel

    Tuberculous myocarditis has a high mortality rate and is often associated with a delay in the diagnosis because of the low index of suspicion and insidious course. Most of the reported cases predominantly occur in young, immunocompetent patients. Delays in diagnosis may result in fatal complications. Through this case report, we aim to shed light on some of the clinical features of tuberculous myocarditis and promote a high index of suspicion for early diagnosis and timely management.


  • Open Access

    Cerebral Venous Sinus Thrombosis in a Patient With Mild Symptoms of COVID-19 Pneumonia

    by Asad Chohan, Farah Chohan, Pedram Rad, George Michel, George Yatzkan

    Although coronavirus disease 2019 (COVID-19) infection is mainly associated with pneumonia, several non-respiratory complications may also occur. Cerebral venous sinus thrombosis (CVST) is a rare but potentially fatal complication of COVID-19 infection. In order to increase awareness about such life-threatening complications to a large population of patients with otherwise mild COVID-19 infection, we present the clinical course of a 29-year-old unvaccinated female who developed CVST, with eight days of mild COVID-19 infection, that proved fatal despite adequate therapeutic measures. Clinicians should carefully consider the risk of thrombosis in patients who present with COVID-19 infection regardless of the intensity of the disease, including prophylaxis (to reduce the risk of hypercoagulable complications) and treatment beyond discharge. More data and research is needed to identify COVID-19 as an independent risk factor for thromboembolism so that future efforts can be aimed at appropriate management e.g. with prophylactic anticoagulants to avoid such complications. In case of unexplained neurological manifestations in patients with an active or recent COVID-19 infection, early investigations for cerebrovascular integrity should be done by using MRI and magnetic resonance angiography (MRA)/magnetic resonance venography (MRV).

  • Open Access

    Clinical Presentation of a COVID-19 Delta Variant Patient: Case Report and Literature Review

    by Farah Chohan, Angela Ishak, Tyler Alderette, Pedram Rad, George Michel

    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes severe bilateral pneumonia and acute respiratory distress syndrome (ARDS) which can lead to difficulty breathing. Many cases require mechanical ventilation and intensive care unit management. The need for mechanical ventilation and ICU admission seems to be more evident in patients that were unvaccinated for COVID-19 at the time of admission. We discuss a case of a 63-year-old African-American woman who presented as a transfer to our hospital facility with acute hypoxic respiratory failure. She was already intubated and mechanically ventilated prior to her transfer. She had a one-week history of shortness of breath and cough productive of white, blood-tinged sputum. A two-day history of diarrhea was also reported before admission to the other hospital where she stayed for a week before transfer to our intensive care unit. She had no significant past medical history and was unvaccinated for COVID-19, and was suspected to be infected with the Delta strain of COVID-19. Her primary diagnosis at admission was COVID pneumonia and acute hypoxic respiratory failure. Her condition worsened over a period of one week. Chest X-Ray, at the time of arrival, showed bilateral patchy opacities consistent with COVID-19 pneumonia. After an extensive review of her labs and reports, the patient was attributed to be at a high risk for acute decompensation (or catastrophically ill), thus requiring critical care management. Over a course of 12 days, she was aggressively treated with antibiotics, steroids, remdesivir and tocilizumab. Her condition gradually deteriorated and she eventually passed away. It can be noted that most of the severe cases, especially ICU admissions, comprise people who are unvaccinated. We can safely conclude that although vaccination may not prevent re-infection, it does result in better clinical outcomes.


  • Open Access

    Hypoxic-Ischemic Encephalopathy-Induced Seizure in an 11-Year-Old Female

    by Krunal Pandav, Angela Ishak, Farah Chohan, Omoyeme Edaki, Jonathan Quinonez, Samir Ruxmohan

    Hypoxic-ischemic encephalopathy (HIE) typically manifests in the neonatal period. The degree of hypoxia following intrapartum asphyxia determines the structural changes in the brain, which can cause functional deficits in the affected child leading to developmental deficits and recurrent seizures. Management requires physical therapy, occupational therapy, and anti-seizure medications. We present a rare case of an 11-year-old female with a past medical history of epilepsy and cerebral atrophy secondary to hypoxic injury at birth. The patient presented to the hospital following a witnessed seizure and loss of consciousness for one hour. Given the past medical history and clinical findings, it was determined that a mild-to-moderate encephalopathic process resulted in a lower seizure threshold. HIE can manifest beyond the neonate years mainly due to the structural changes within the brain. Therefore, it is essential to understand aspects of HIE beyond the neonate years to manage this condition for a better patient outcome.